SHANDONG BOAN BIOTECH.H 1 (UJ9) — Cash Flow-to-Debt Ratio
SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Cash Flow-to-Debt Ratio of 0.05x as of December 2025, meaning its operating cash flow of €64.89 Million could theoretically repay 0% of its total liabilities (€1.39 Billion) in one year. See SHANDONG BOAN BIOTECH.H 1 leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
SHANDONG BOAN BIOTECH.H 1 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for SHANDONG BOAN BIOTECH.H 1 across 5 annual periods. For the full cash flow conversion analysis, see SHANDONG BOAN BIOTECH.H 1 cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for SHANDONG BOAN BIOTECH.H 1 (2021–2025)
Year-by-year debt coverage analysis for SHANDONG BOAN BIOTECH.H 1. Check UJ9 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | €64.89 Million | €1.39 Billion | ▲ +147.9% |
| 2024 | -0.10x | €-117.94 Million | €1.21 Billion | ▼ -428.0% |
| 2023 | -0.02x | €-18.57 Million | €1.00 Billion | ▲ +92.8% |
| 2022 | -0.26x | €-201.84 Million | €784.18 Million | ▲ +42.0% |
| 2021 | -0.44x | €-246.28 Million | €554.92 Million | — |